- Home
- HELE vs TVTX Comparison
HELE vs TVTX Comparison
Compare HELE & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HELE
- TVTX
- Stock Information
- Founded
- HELE 1968
- TVTX 2008
- Country
- HELE United States
- TVTX United States
- Employees
- HELE N/A
- TVTX N/A
- Industry
- HELE Home Furnishings
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- HELE Consumer Discretionary
- TVTX Health Care
- Exchange
- HELE Nasdaq
- TVTX Nasdaq
- Market Cap
- HELE 1.2B
- TVTX 1.3B
- IPO Year
- HELE N/A
- TVTX N/A
- Fundamental
- Price
- HELE $64.92
- TVTX $17.72
- Analyst Decision
- HELE Buy
- TVTX Buy
- Analyst Count
- HELE 3
- TVTX 13
- Target Price
- HELE $78.33
- TVTX $23.46
- AVG Volume (30 Days)
- HELE 352.7K
- TVTX 1.4M
- Earning Date
- HELE 01-06-2025
- TVTX 10-31-2024
- Dividend Yield
- HELE N/A
- TVTX N/A
- EPS Growth
- HELE 5.17
- TVTX N/A
- EPS
- HELE 6.03
- TVTX N/A
- Revenue
- HELE $1,929,883,000.00
- TVTX $203,447,000.00
- Revenue This Year
- HELE N/A
- TVTX $62.45
- Revenue Next Year
- HELE $1.08
- TVTX $59.30
- P/E Ratio
- HELE $10.77
- TVTX N/A
- Revenue Growth
- HELE N/A
- TVTX 57.08
- 52 Week Low
- HELE $48.05
- TVTX $5.12
- 52 Week High
- HELE $127.83
- TVTX $20.33
- Technical
- Relative Strength Index (RSI)
- HELE 51.37
- TVTX 51.53
- Support Level
- HELE $61.80
- TVTX $16.89
- Resistance Level
- HELE $67.24
- TVTX $19.51
- Average True Range (ATR)
- HELE 2.26
- TVTX 1.23
- MACD
- HELE -0.11
- TVTX -0.16
- Stochastic Oscillator
- HELE 51.91
- TVTX 26.69
About HELE Helen of Troy Limited
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home & Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty & Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.